S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
S&P 500   4,577.11
DOW   35,368.47
QQQ   370.55
OTCMKTS:CBIS

Cannabis Science Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.0050
0.00 (0.00%)
(As of 11/27/2019)
Add
Compare
Today's Range
$0.01
$0.01
50-Day Range
$0.01
$0.01
52-Week Range
$0.00
$0.06
Volume
N/A
Average Volume
4.85 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A

Receive CBIS News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Science and its competitors with MarketBeat's FREE daily newsletter.


Cannabis Science logo

About Cannabis Science

Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, benefits of medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug; and a research collaboration agreement with Dana-Farber Cancer Institute, Inc. to develop and investigate the use of cannabinoids to cure various cancers, as well as with Stellenbosch University to treat chronic pelvic pain associated with pelvic inflammatory disease in women, chronic prostatitis in men, and other chronic pain associated with other indications. The company was formerly known as Gulf Onshore, Inc. and changed its name to Cannabis Science, Inc. in April 2009. The company was incorporated in 1996 and is based in Irvine, California. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.

Headlines

News for Cannabis Science Inc
November 16, 2020 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Cannabis
Sector
Medical
Current Symbol
OTCMKTS:CBIS
CUSIP
137648101
Fax
N/A
Employees
N/A
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

Company Calendar

Last Earnings
7/28/2015
Today
1/19/2022

MarketRank

Overall MarketRank

0.93 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Cannabis Science (OTCMKTS:CBIS) Frequently Asked Questions

How were Cannabis Science's earnings last quarter?

Cannabis Science Inc (OTCMKTS:CBIS) announced its quarterly earnings results on Tuesday, July, 28th. The company reported $0.00 EPS for the quarter.
View Cannabis Science's earnings history
.

Who are Cannabis Science's key executives?

Cannabis Science's management team includes the following people:
  • Mr. Raymond C. Dabney, Co-Founder, Chairman, CEO & Pres (Age 54)
  • Mr. Benjamin C. K. Tam, CFO, Sec. & Director (Age 67)
  • Mr. Robert James Kane, COO & Director (Age 43)
  • Mr. Mario Lap, Pres of European Operations & Director (Age 67)
  • Mr. Bret Bogue, Director of Horticulture and Head of R&D

What other stocks do shareholders of Cannabis Science own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Science investors own include Medical Marijuana (MJNA), (CGC), Unrivaled Brands (TRTC), (XXII), Hemp (HEMP), Aurora Cannabis (ACBFF), Cronos Group (CRON), Aurora Cannabis (ACB), KushCo (KSHB) and Energous (WATT).

What is Cannabis Science's stock symbol?

Cannabis Science trades on the OTCMKTS under the ticker symbol "CBIS."

What is Cannabis Science's stock price today?

One share of CBIS stock can currently be purchased for approximately $0.01.

What is Cannabis Science's official website?

The official website for Cannabis Science is www.cannabisscience.com.

Where are Cannabis Science's headquarters?

How can I contact Cannabis Science?

Cannabis Science's mailing address is 19800 Macarthur Blvd Ste 300, IRVINE, CA 92612-2479, United States. The company can be reached via phone at +1-888-8890888.


This page was last updated on 1/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.